Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Oropharyngeal Neoplasms 12Lung Neoplasms 9Carcinoma 8Mouth Neoplasms 7Laryngeal Neoplasms 7Mesothelioma, Malignant 6Hypopharyngeal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Nasopharyngeal Carcinoma 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Testicular Neoplasms 2Seminoma 2Medulloblastoma 2Ganglioneuroblastoma 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Tongue Neoplasms 1Teratoma 1

Interventions

sodium thiosulfate 1ebselen 1Platinum 1Magnetic Resonance Spectroscopy 1Hearing Tests 1Hearing 1Cisplatin 1Atorvastatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hearing Loss × Platinum × 90 days × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡